CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 2, Pages e56380
Publisher
Public Library of Science (PLoS)
Online
2013-02-12
DOI
10.1371/journal.pone.0056380
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytoplasmic CD133 Expression is a Reliable Prognostic Indicator of Tumor Regression After Neoadjuvant Concurrent Chemoradiotherapy in Patients with Rectal Cancer
- (2012) Shu-Wen Jao et al. ANNALS OF SURGICAL ONCOLOGY
- Mutations in the Ras-Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
- (2012) K. Kemper et al. CLINICAL CANCER RESEARCH
- Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinoma
- (2012) Hong Li et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients
- (2012) Claudio Coco et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer
- (2012) Kumiko Hongo et al. MEDICAL ONCOLOGY
- Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients
- (2012) Luca Reggiani Bonetti et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer
- (2011) Hisae Iinuma et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma
- (2011) H.-Q. Xi et al. JOURNAL OF CLINICAL PATHOLOGY
- Is CD133 mRNA expression a prognostic factor in colorectal cancer?
- (2011) Tamuro Hayama et al. JOURNAL OF SURGICAL ONCOLOGY
- Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis
- (2011) Xiaodong Huang et al. SURGICAL ONCOLOGY-OXFORD
- Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM and ALDH1 in colorectal cancer
- (2010) A Lugli et al. BRITISH JOURNAL OF CANCER
- Clinical Significance of CD133 and Hypoxia Inducible Factor-1α Gene Expression in Rectal Cancer after Preoperative Chemoradiotherapy
- (2010) S. Saigusa et al. CLINICAL ONCOLOGY
- Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy
- (2010) V. Moreno García et al. Colorectal Disease
- CD133 mRNA expression and microsatellite instability in colorectal carcinoma
- (2010) Jung Wook Huh et al. JOURNAL OF SURGICAL ONCOLOGY
- CD133 expression predicts for non-response to chemotherapy in colorectal cancer
- (2010) Chee W Ong et al. MODERN PATHOLOGY
- Predictive Value of Cancer Stem-Like Cells and Cancer-Associated Genetic Markers for Peritoneal Recurrence of Colorectal Cancer in Patients after Curative Surgery
- (2010) Keisuke Nakamura et al. ONCOLOGY
- Immunohistochemical features of CD133 expression: Association with resistance to chemoradiotherapy in rectal cancer
- (2010) Saigusa ONCOLOGY REPORTS
- Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients
- (2010) Takahashi ONCOLOGY REPORTS
- Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
- (2009) Susumu Saigusa et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer
- (2009) David Horst et al. CANCER INVESTIGATION
- CD133 expression in rectal cancer after preoperative chemoradiotherapy
- (2009) Motohiro Kojima et al. CANCER SCIENCE
- CD133 and nuclear β-catenin: The marker combination to detect high risk cases of low stage colorectal cancer
- (2009) David Horst et al. EUROPEAN JOURNAL OF CANCER
- Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients
- (2009) R. Artells et al. EUROPEAN JOURNAL OF CANCER
- Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer
- (2009) Qi Wang et al. HISTOPATHOLOGY
- The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer
- (2009) David Horst et al. JOURNAL OF PATHOLOGY
- Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
- (2009) Chun-Yan Li et al. Journal of Translational Medicine
- Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma
- (2009) Dongho Choi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer
- (2008) László Herszényi et al. BMC CANCER
- CD133 expression is an independent prognostic marker for low survival in colorectal cancer
- (2008) D Horst et al. BRITISH JOURNAL OF CANCER
- CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer
- (2008) S Maeda et al. BRITISH JOURNAL OF CANCER
- Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study
- (2008) Motohiro Kojima et al. CANCER SCIENCE
- The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells
- (2008) Scott Bidlingmaier et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity
- (2008) L. Vermeulen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of CD133-1 and CD133-2 in ovarian cancer
- (2007) G. FERRANDINA et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now